Veritas Investment Management UK Ltd increased its position in CVS Health Corp (NYSE:CVS) by 1.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 185,104 shares of the pharmacy operator’s stock after purchasing an additional 2,995 shares during the quarter. CVS Health makes up about 5.7% of Veritas Investment Management UK Ltd’s investment portfolio, making the stock its 8th largest holding. Veritas Investment Management UK Ltd’s holdings in CVS Health were worth $14,893,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of the business. Bank of America Corp DE lifted its position in shares of CVS Health by 1.8% in the first quarter. Bank of America Corp DE now owns 22,411,957 shares of the pharmacy operator’s stock valued at $1,759,338,000 after acquiring an additional 398,999 shares in the last quarter. Macquarie Group Ltd. increased its holdings in shares of CVS Health by 2.4% in the first quarter. Macquarie Group Ltd. now owns 9,752,261 shares of the pharmacy operator’s stock worth $765,534,000 after purchasing an additional 225,981 shares during the last quarter. Clearbridge Investments LLC increased its holdings in shares of CVS Health by 6.8% in the first quarter. Clearbridge Investments LLC now owns 9,258,404 shares of the pharmacy operator’s stock worth $726,785,000 after purchasing an additional 589,646 shares during the last quarter. Veritas Asset Management LLP increased its holdings in shares of CVS Health by 11.4% in the second quarter. Veritas Asset Management LLP now owns 8,438,564 shares of the pharmacy operator’s stock worth $678,967,000 after purchasing an additional 865,756 shares during the last quarter. Finally, Pioneer Investment Management Inc. increased its holdings in shares of CVS Health by 4.6% in the first quarter. Pioneer Investment Management Inc. now owns 8,033,087 shares of the pharmacy operator’s stock worth $630,598,000 after purchasing an additional 353,621 shares during the last quarter. 82.24% of the stock is owned by institutional investors and hedge funds.
Several brokerages have recently issued reports on CVS. Royal Bank Of Canada set a $95.00 target price on CVS Health and gave the stock a “buy” rating in a report on Monday. Robert W. Baird set a $77.00 price objective on CVS Health and gave the stock a “hold” rating in a research note on Monday. Jefferies Group set a $76.00 target price on CVS Health and gave the company a “hold” rating in a research note on Monday. Loop Capital set a $73.00 target price on CVS Health and gave the company a “hold” rating in a research note on Monday. Finally, Citigroup set a $76.00 price target on CVS Health and gave the company a “hold” rating in a report on Monday. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the company. CVS Health presently has an average rating of “Buy” and a consensus price target of $86.35.
Shares of CVS Health Corp (NYSE:CVS) traded down $3.43 on Monday, reaching $71.69. The company’s stock had a trading volume of 40,462,409 shares, compared to its average volume of 6,844,018. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.72. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55. The firm has a market cap of $72,620.00, a P/E ratio of 13.16, a P/E/G ratio of 1.29 and a beta of 0.89.
CVS Health (NYSE:CVS) last posted its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the firm earned $1.64 EPS. analysts predict that CVS Health Corp will post 5.9 earnings per share for the current fiscal year.
In other news, insider Larry J. Merlo sold 241,150 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $83.07, for a total transaction of $20,032,330.50. Following the completion of the sale, the insider now owns 299,255 shares in the company, valued at approximately $24,859,112.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Jonathan C. Roberts sold 85,743 shares of CVS Health stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $83.14, for a total transaction of $7,128,673.02. Following the completion of the sale, the chief operating officer now owns 119,555 shares of the company’s stock, valued at approximately $9,939,802.70. The disclosure for this sale can be found here. Insiders sold a total of 714,125 shares of company stock worth $58,119,381 over the last three months. Corporate insiders own 0.61% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This story was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/04/veritas-investment-management-uk-ltd-purchases-2995-shares-of-cvs-health-corporation-cvs.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.